Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro A Torres-Saavedra

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics|August 7, 2021
An Overview of Phase 2 Clinical Trial DesignsPedro A Torres-Saavedra, Kathryn A Winter
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 2021
Fundamental Statistical Concepts in Clinical Trials and Diagnostic TestingStephanie L Pugh, Pedro A Torres-Saavedra
Traffic Injury Prevention|July 30, 2019
The utility of delta 9-tetrahydrocannabinol (THC) measures obtained from oral fluid samples in traffic safetyEduardo Romano, Christine Moore, Tara Kelley-Baker, et al.
Clinical Trials (London, England)|January 3, 2026
A note on rank-preserving structural failure time models to account for crossoverPedro A Torres-Saavedra, Boris Freidlin, Jong-Hyeon Jeong, et al.
Journal of Studies on Alcohol and Drugs|August 7, 2018
Alcohol-Related Risk of Driver Fatalities in Motor Vehicle Crashes: Comparing Data From 2007 and 2013-2014Eduardo Romano, Pedro A Torres-Saavedra, Hilda I Calderón Cartagena, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 23, 2026
AI-Assisted HER2 Scoring in Breast Cancer: Diagnostic Agreement and Understanding DiscordanceFrederik Deman, Dusan Rasic, Glenn Broeckx, et al.
Journal of the National Cancer Institute. Monographs|February 24, 2025
Best practices and pragmatic approaches for patient-reported outcomes and quality of life measures in cancer clinical trialsHanna Bandos, Pedro A Torres-Saavedra, Eva Culakova, et al.
The Lancet. Oncology|October 3, 2024
Challenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Sarah Cannon Research Institute, and the American College of Radiation Oncology (ACRO)Zachary S Zumsteg, Siddharth Sheth, Salma K Jabbour, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 2022
Nodal Metastasis Count and Oncologic Outcomes in Head and Neck Cancer: A Secondary Analysis of NRG/RTOG 9501, NRG/RTOG 0234, and EORTC 22931Diana J Lu, Michael Luu, Christopher Gay, et al.
International Journal of Radiation Oncology, Biology, Physics|March 13, 2026
Quality of life in patients with p16+ oropharyngeal cancer receiving accelerated radiotherapy with either cisplatin or cetuximab in the NRG/RTOG 1016 randomized controlled trialJolie Ringash, Pedro A Torres-Saavedra, Maura L Gillison, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|August 7, 2021
An Overview of Phase 2 Clinical Trial DesignsPedro A Torres-Saavedra, Kathryn A Winter
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 2021
Fundamental Statistical Concepts in Clinical Trials and Diagnostic TestingStephanie L Pugh, Pedro A Torres-Saavedra
Traffic Injury Prevention|July 30, 2019
The utility of delta 9-tetrahydrocannabinol (THC) measures obtained from oral fluid samples in traffic safetyEduardo Romano, Christine Moore, Tara Kelley-Baker, et al.
Clinical Trials (London, England)|January 3, 2026
A note on rank-preserving structural failure time models to account for crossoverPedro A Torres-Saavedra, Boris Freidlin, Jong-Hyeon Jeong, et al.
Journal of Studies on Alcohol and Drugs|August 7, 2018
Alcohol-Related Risk of Driver Fatalities in Motor Vehicle Crashes: Comparing Data From 2007 and 2013-2014Eduardo Romano, Pedro A Torres-Saavedra, Hilda I Calderón Cartagena, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 23, 2026
AI-Assisted HER2 Scoring in Breast Cancer: Diagnostic Agreement and Understanding DiscordanceFrederik Deman, Dusan Rasic, Glenn Broeckx, et al.
Journal of the National Cancer Institute. Monographs|February 24, 2025
Best practices and pragmatic approaches for patient-reported outcomes and quality of life measures in cancer clinical trialsHanna Bandos, Pedro A Torres-Saavedra, Eva Culakova, et al.
The Lancet. Oncology|October 3, 2024
Challenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Sarah Cannon Research Institute, and the American College of Radiation Oncology (ACRO)Zachary S Zumsteg, Siddharth Sheth, Salma K Jabbour, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 2022
Nodal Metastasis Count and Oncologic Outcomes in Head and Neck Cancer: A Secondary Analysis of NRG/RTOG 9501, NRG/RTOG 0234, and EORTC 22931Diana J Lu, Michael Luu, Christopher Gay, et al.
International Journal of Radiation Oncology, Biology, Physics|March 13, 2026
Quality of life in patients with p16+ oropharyngeal cancer receiving accelerated radiotherapy with either cisplatin or cetuximab in the NRG/RTOG 1016 randomized controlled trialJolie Ringash, Pedro A Torres-Saavedra, Maura L Gillison, et al.
Pageof 3